findmyKOL
Clinical trialNCT02454933CompletedPhase 3Interventional

Study of AZD9291 Plus MEDI4736 Versus AZD9291 Monotherapy in NSCLC After Previous EGFR TKI Therapy in T790M Mutation Positive Tumours

SponsorAstraZenecaEnrollment29Locally Advanced or Metastatic EGFR T790M+ NSCLC
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Research Site

    Toronto, Ontario, Canada

South Korea
  • Research Site

    Busan, South Korea

  • Research Site

    Daegu, South Korea

  • Research Site

    Incheon, South Korea

  • Research Site

    Jinju, South Korea

  • Research Site

    Seongnam-si, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Seoul, South Korea

  • Research Site

    Ulsan, South Korea

Taiwan
  • Research Site

    Kaohsiung City, Taiwan

  • Research Site

    Taichung, Taiwan

  • Research Site

    Taipei, Taiwan

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
15 Jul 2015
Primary completion
21 Aug 2017
Completion
21 Jun 2023
Last update posted
19 Sept 2024
Registered enrollment
29
Registry id
NCT02454933

Cross-registrations

EU-CTR / CTIS (EudraCT)2015-001858-15
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.